References
- The Definition and Classification of Dry Eye Disease: Report of the Definition and Classification Subcommittee of the International Dry Eye WorkshopOcul Surf200752759217508116
- The Epidemiology of Dry Eye Disease: Report of the Epidemiology Subcommittee of the International Dry Eye WorkshopOcul Surf200759310717508117
- Management and therapy of dry eye disease: Report of the Management and Therapy Subcommittee of the International Dry Eye WorkshopOcul Surf2007516317817508120
- Restasis® [prescribing information]Irvine, CAAllergan, Inc2009
- PerryHDSolomonRDonnenfeldEDValuation of topical cyclosporine for the treatment of dry eye diseaseArch Ophthalmol20081261046105018695097
- WalkerPMLaneKJOuslerGW3rdAbelsonMBDiurnal variation of visual function and the signs and symptoms of dry eyeCornea20102960761220458235
- PflugfelderSCAntiinflammatory therapy for dry eyeAm J Ophthalmol200413733734214962426
- LuoLLiDQCorralesRMPflugfelderSCHyperosmolar saline is a proinflammatory stress on the mouse ocular surfaceEye Contact Lens20053118619316163009
- LuoLLiDQDoshiAExperimental dry eye stimulates production of inflammatory cytokines and MMP-9 and activates MAPK signaling pathways on the ocular surfaceInvest Ophthal Vis Sci2004454293430115557435
- HuangAJWImmunosuppressive therapy for ocular surface disordersDry Eye and Ocular Surface DisordersPflugfelderSCBeuermanRWSternMENew York, NYMarcel Dekker, Inc2004
- BarnesPJCorticosteroid effects on cell signallingEur Respir J20062741342616452600
- American Academy of Ophthalmology Cornea/External Disease PanelPreferred Practice Pattern: Dry Eye SyndromeSan Francisco, CAAmerican Academy of Ophthalmology2008
- ChunDKShapiroAAbelsonMBOcular PharmacokineticsPrinciples and Practice of Ophthalmology3rd edAlbertDMMillerJWToronto, ONElsevier Inc2008
- GhateDEdelhauserHFOcular drug deliveryExpert Opin Drug Deliv2006327528716506953
- LiJTripathiRCTripathiBJDrug-induced ocular disordersDrug Safety20083112714118217789
- Von SallmannLIontophoretic introduction of atropine and scopolamine into the rabbit eyeArch Ophthalmol194329711719
- HughesLMauriceDMA fresh look at iontophoresisArch Ophthalmol1984102182518296508622
- JonesRFMauriceDMNew methods of measuring the rate of aqueous flow in man with fluoresceinExp Eye Res196652082205914653
- LamTTEdwardDPZhuXATsoMOTransscleral iontophoresis of dexamethasoneArch Ophthalmol1989107136813712783069
- Horwath-WinterJSchmutOHaller-SchoberEMIodide iontophoresis as a treatment for dry eye syndromeBr J Ophthalmol200589404415615744
- KaliaYNNaikAGarrisonJGuyRHIontophoretic drug deliveryAdv Drug Deliv Rev20045661965815019750
- BudavariSDexamethasoneThe Merck Index: An Encyclopedia of Chemicals, Drugs, and Biologicals14th edO’NeilMJWhitehouse Station, NJMerck and Co2006
- GüngörSDelgado-CharroMBRuiz-PerezBTrans-scleral iontophoretic delivery of low molecular weight therapeuticsJ Controlled Release2010147225231
- Ruiz-PerezBDowieTGeeRIsomPManzoMSkokanovaETransscleral delivery of a 12.4 kDa protein by ocular iontophoresisInvest Ophthalmol Vis Sci2008491813
- OuslerGWIIIGomesPJWelchDAbelsonMBMethodologies for the study of ocular surface diseaseOcul Surf2005314315417131019
- OuslerGWIIIAndersonRTOsbornKEThe effect of senofilcon A contact lenses compared to habitual contact lenses on ocular discomfort during exposure to a controlled adverse environmentCurr Med Res Opin20082433534118073007
- González-GarcíaMJGonzález-SáizAExposure to a controlled adverse environment impairs the ocular surface of patients with minimally symptomatic dry eyeInvest Ophthalmol Vis Sci2007484026403217724183
- OuslerGWIIIWilcoxKAGuptaGAbelsonMBAn evaluation of the ocular drying effects of 2 systemic antihistamines: loratadine and cetirizine hydrochlorideAnn Allergy Asthma Immunol20049346046415562885
- CramptonHJOuslerGWPflugfelderSCorrelation of the Controlled Adverse Environment (CAE) model with a murine model of experimental dry eye in assessing the ability of topical doxycycline to prevent corneal barrier disruptionInvest Ophthalmol Vis Sci200748402
- OuslerGWIIIHagbergKWSchindelarMThe Ocular Protection IndexCornea20082750951318520496
- AtkinsonKAAn Introduction to Numerical Analysis2nd edNew YorkJohn Wiley & Sons1989
- HalhalMRenardGCourtoisYIontophoresis: from the lab to the bed sideExp Eye Res20047875175715106955
- CohenAPataneMAReddyMAssangCFromSClinical Experience with the EyeGate® II Delivery System (EGDS): Safety and Tolerability in Healthy Adult VolunteersInvest Ophthalmol Vis Sci2011523224
- PataneMCohenASugarmanJFromSRandomized, double-masked study of four iontophoresis dose levels of EGP-437 in non-infectious anterior segment uveitis subjectsInvest Ophthalmol Vis Sci2010515263